|
Parameters
|
TXB2
|
5-HETE
|
12-HETE
|
15-HETE
|
|---|
|
Gender
|
NS
|
NS
|
NS
|
NS
|
|
Renal replacement therapy and duration of dialysis
|
< 0,001
|
NS
|
< 0,001
|
< 0,001
|
|
Renal replacement therapy and age
|
< 0,001
|
< 0,001
|
< 0,001
|
< 0,001
|
|
Stage of CKD
|
NS
|
0,003
|
NS
|
NS
|
|
Causes of CKD
|
NS
|
NS
|
NS
|
NS
|
- The table presents p values defining statistical significance. The relationship between gender, duration of dialysis, age, stage of chronic kidney disease and the causes of chronic kidney disease and the concentrations of arachidnonic acid derivatives was assessed using one-way ANOVA
- HD and duration of dialysis - the relationship between the type of therapy (hemodialysis, peritoneal dialysis, patients before kidney transplantation), duration of dialysis and the concentrations of arachidnonic acid derivatives
- HD and age - dependence between the studied groups (hemodialysis, peritoneal dialysis, conservative treatment, patients before kidney transplantation and control group), patients’ age and concentrations of arachidnonic acid derivatives
- The stage of chronic kidney disease - the relationship between the severity of chronic kidney disease based on eGFR and the activity of concentrations of arachidnonic acid derivatives
- The causes of chronic kidney disease - the relationship between selected causes of chronic disease and the concentrations of arachidnonic acid derivatives
- NS - no statistically significant relationship was found
